XML 24 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions, Investments, and Licenses - Schedule of Consolidated Assets and Non-Recourse Liabilities (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Sep. 30, 2013
Dec. 31, 2012
Current assets:        
Cash and cash equivalents $ 118,258 [1] $ 185,798 [1] $ 155,834 $ 27,361
Accounts receivable, net 21,210 [1] 19,767 [1]    
Inventory, net 16,662 [1] 18,079 [1]    
Prepaid expenses and other current assets 7,018 [1] 19,084 [1]    
Total current assets 163,148 [1] 242,728 [1]    
Property, plant and equipment, net 17,036 [1] 17,027 [1]    
Intangible assets, net 65,553 [1] 74,533 [1]    
Goodwill 224,769 [1] 226,373 [1]    
Other assets 4,673 [1] 6,861 [1]    
Total assets 1,295,242 [1] 1,391,516 [1]    
Current liabilities:        
Accounts payable 8,841 [1] 13,414 [1]    
Accrued expenses 55,554 [1] 65,874 [1]    
Total current liabilities 76,841 [1] 91,850 [1]    
Other long-term liabilities 216,174 [1] 214,775 [1]    
Total liabilities 407,898 [1] 518,537 [1]    
SciVac | Variable Interest Entity, Primary Beneficiary
       
Current assets:        
Cash and cash equivalents 57 2    
Accounts receivable, net 422 283    
Inventory, net 1,650 1,696    
Prepaid expenses and other current assets 599 218    
Total current assets 2,728 2,199    
Property, plant and equipment, net 1,828 1,374    
Intangible assets, net 951 1,111    
Goodwill 1,634 1,821    
Other assets 255 261    
Total assets 7,396 6,766    
Current liabilities:        
Accounts payable 843 1,136    
Accrued expenses 5,481 6,498    
Notes payable 4,193 1,537    
Total current liabilities 10,517 9,171    
Other long-term liabilities 2,568 1,240    
Total liabilities $ 13,085 $ 10,411    
[1] As of September 30, 2014 and December 31, 2013, total assets include $7.4 million and $6.7 million, respectively, and total liabilities include $13.1 million and $10.4 million, respectively, related to SciVac Ltd (“SciVac”), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 5.